Anti-inflammatory effects of pioglitazone on iron-induced oxidative injury in the nigrostriatal dopaminergic system

Neuropathology and Applied Neurobiology
H C YuAnya Maan-Yuh Lin

Abstract

Transition metals, oxidative stress and neuroinflammation have been proposed as part of a vicious cycle in central nervous system neurodegeneration. Our aim was to study the anti-inflammatory effect of pioglitazone, a peroxisome proliferative activated receptor-γ agonist, on iron-induced oxidative injury in rat brain. Intranigral infusion of ferrous citrate (iron) was performed on anaesthetized rats. Pioglitazone (20 mg/kg) was orally administered. Oxidative injury was investigated by measuring lipid peroxidation in the substantia nigra (SN) and dopamine content in the striatum. Western blot assay and DNA fragmentation were employed to study the involvement of α-synuclein aggregation, neuroinflammation as well as activation of endoplasmic reticulum (ER) and mitochondrial pathways in iron-induced apoptosis. Intranigral infusion of iron time-dependently increased α-synuclein aggregation and haem oxygenase-1 levels. Furthermore, apoptosis was demonstrated by TUNEL-positive cells and DNA fragmentation in the iron-infused SN. Systemic pioglitazone was found to potentiate iron-induced elevation in nuclear peroxisome proliferative activated receptor-γ levels. However, pioglitazone inhibited iron-induced α-synuclein aggregation, elevat...Continue Reading

References

Mar 1, 1991·Journal of Neurochemistry·E SoficM B Youdim
Dec 1, 1991·Journal of Neurochemistry·D Ben-Shachar, M B Youdim
Aug 1, 1986·Journal of Neurosurgery·T W HoodJ L Venes
Oct 1, 1986·Physiology & Behavior·J P Kroon, A L Riley
Apr 1, 1984·The Biochemical Journal·B Halliwell, J M Gutteridge
Jan 1, 1994·Movement Disorders : Official Journal of the Movement Disorder Society·D T DexterC D Marsden
Dec 1, 1996·Neurology·P Jenner, C W Olanow
Feb 24, 1998·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·P RauhalaC C Chiueh
May 30, 1998·Proceedings of the National Academy of Sciences of the United States of America·M G SpillantiniM Goedert
May 10, 2000·Free Radical Biology & Medicine·A M Lin, L T Ho
Jun 22, 2000·Archives of Biochemistry and Biophysics·S R PaikJ H Lee
Jan 31, 2002·Annual Review of Medicine·Joel Berger, David E Moller
Feb 19, 2002·The Journal of Biological Chemistry·Natalie GoltsBenjamin Wolozin
Dec 25, 2004·Stroke; a Journal of Cerebral Circulation·Tomokazu ShimazuJoel H Greenberg
Mar 26, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Wei ZhangJing Zhang
Aug 24, 2005·Antioxidants & Redox Signaling·Ralf Dringen
Oct 22, 2005·Annals of Neurology·Honglei ChenAlberto Ascherio
Jun 13, 2006·Neurochemistry International·Sophia SundararajanGary Landreth
Jun 14, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Yi ZhaoJuraj Culman
Jun 15, 2006·Antioxidants & Redox Signaling·Ramendra N Saha, Kalipada Pahan
Sep 6, 2006·Experimental & Molecular Medicine·Yoon Seong Kim, Tong H Joh
Nov 2, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Tetyana DukaAnita Sidhu
Jan 27, 2007·Biochemical and Biophysical Research Communications·J J M HoozemansW Scheper
Mar 7, 2007·British Journal of Pharmacology·P S Whitton
May 1, 2007·Antioxidants & Redox Signaling·Hua-Qin Wang, Ryosuke Takahashi
Aug 7, 2007·International Review of Neurobiology·Ashley ReynoldsHoward E Gendelman
Aug 2, 2008·Journal of Cellular and Molecular Medicine·Cintia RoodveldtChristopher M Dobson
Dec 11, 2008·Acta Neurochirurgica. Supplement·Y HuaG Xi
Mar 28, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Josephine A WrightDavid R Brown
May 22, 2009·Journal of Neurochemistry·Hyman M SchipperDavid Zeligman
Jul 1, 2009·Neurochemistry International·Parto S Khansari, Robert F Halliwell
Jul 15, 2009·Clinical and Experimental Pharmacology & Physiology·Li-Xia LouChao-Shu Tang

❮ Previous
Next ❯

Citations

Oct 29, 2013·European Journal of Pharmacology·Hassan MalekinejadAli Rezaei-Golmisheh
Sep 2, 2014·Pesticide Biochemistry and Physiology·Hassan MalekinejadAmir Amniattalab
Mar 7, 2012·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·C LalouxR Bordet
Oct 8, 2015·Journal of Parkinson's Disease·David K SimonUNKNOWN NINDS NET-PD Investigators
Jul 8, 2014·Oxidative Medicine and Cellular Longevity·Antonio AyalaSandro Argüelles
Jan 27, 2012·International Journal of Cardiology·Aiko SakamotoNobukazu Ishizaka
May 4, 2011·Progress in Neurobiology·Werner J GeldenhuysCornelis J Van der Schyf
Oct 23, 2012·Experimental Neurology·Dirk A Ridder, Markus Schwaninger
Mar 23, 2017·Scientific Reports·Alexander M Horspool, Howard C Chang
Dec 9, 2010·Journal of Neurochemistry·Jeswinder Sian-HülsmannPeter Riederer
Apr 15, 2020·International Journal of Molecular Sciences·Yujie ShiSiyu Chen
Mar 2, 2021·Neurochemical Research·Xiaoyan ZengDongya Huang
Mar 17, 2021·Seminars in Cell & Developmental Biology·Ana M Daugherty
Aug 28, 2012·Journal of Agricultural and Food Chemistry·Anya Maan-Yuh LinLucy Sun Hwang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Alpha-Synuclein Aggregation

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis